We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OAK
1351
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$3.95M 0.01%
79,822
-33,693
-30% -$1.67M
SCI icon
1352
Service Corp International
SCI
$11.6B
$3.93M 0.01%
84,102
-11,993
-12% -$518K
VNQI icon
1353
Vanguard Global ex-US Real Estate ETF
VNQI
$3.57B
$3.93M 0.01%
66,580
+5,227
+9% +$306K
VYMI icon
1354
Vanguard International High Dividend Yield ETF
VYMI
$21.3B
$3.92M 0.01%
63,935
+910
+1% +$55.7K
THO icon
1355
Thor Industries
THO
$4.14B
$3.91M 0.01%
66,931
+5,793
+9% +$351K
WES icon
1356
Western Midstream Partners
WES
$19.3B
$3.91M 0.01%
127,137
-3,202
-2% -$98.7K
GEF icon
1357
Greif
GEF
$5.04B
$3.9M 0.01%
119,982
+77,302
+181% +$2.88M
ALLE icon
1358
Allegion
ALLE
$14.4B
$3.9M 0.01%
35,265
+6,792
+24% +$679K
FTS icon
1359
Fortis
FTS
$28.7B
$3.88M 0.01%
98,451
-2,017
-2% -$76.3K
AYX
1360
DELISTED
Alteryx Inc
AYX
$3.88M 0.01%
35,507
-44,553
-56% -$4.05M
TCPC icon
1361
BlackRock TCP Capital
TCPC
$345M
$3.87M 0.01%
271,466
-6,369
-2% -$92K
AGX icon
1362
Argan
AGX
$8.37B
$3.85M 0.01%
94,821
-446
-0.5% -$20.9K
BFYT
1363
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$3.85M 0.01%
148,373
+49,197
+50% +$1.24M
SUSB icon
1364
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.3B
$3.84M 0.01%
151,498
+10,026
+7% +$251K
LAMR icon
1365
Lamar Advertising Co
LAMR
$16.3B
$3.83M 0.01%
47,489
+1,363
+3% +$110K
COHR
1366
DELISTED
Coherent Inc
COHR
$3.83M 0.01%
28,084
+574
+2% +$77.5K
FL
1367
DELISTED
Foot Locker
FL
$3.82M 0.01%
91,135
-44,882
-33% -$2.33M
ENOV icon
1368
Enovis
ENOV
$1.53B
$3.82M 0.01%
79,187
-3,790
-5% -$182K
MLNX
1369
DELISTED
Mellanox Technologies, Ltd.
MLNX
$3.81M 0.01%
34,433
-2,050
-6% -$236K
KBE icon
1370
State Street SPDR S&P Bank ETF
KBE
$1.71B
$3.81M 0.01%
87,764
-9,568
-10% -$416K
KRP icon
1371
Kimbell Royalty Partners
KRP
$1.48B
$3.8M 0.01%
235,462
+192,401
+447% +$3.3M
COLB icon
1372
Columbia Banking Systems
COLB
$8.84B
$3.79M 0.01%
104,727
+24,826
+31% +$879K
AABA
1373
DELISTED
Altaba Inc
AABA
$3.78M 0.01%
54,491
-51,274
-48% -$3.59M
UNM icon
1374
Unum
UNM
$14.3B
$3.76M 0.01%
112,206
+16,547
+17% +$573K
NVG icon
1375
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.7B
$3.76M 0.01%
236,643
-40,262
-15% -$625K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.